An Overview of Primary Biliary Cirrhosis, Also Known as Primary Biliary Cholangitis
Anurag Maheshwari, Clinical Assistant Professor of Medicine
Intercept Pharmaceuticals, Inc., invites you to:
The ABCs of PBC: An Overview of Primary Biliary Cirrhosis, Also Known as Primary Biliary Cholangitis
Wednesday, July 31, 2019 at 6:00 PM
Cactus Taverna 2420 North Salisbury Blvd Salisbury, MD 21801
Anurag Maheshwari Clinical Assistant Professor of Medicine University of Maryland School of Medicine Mercy Medical Center Baltimore, MD
FACT or MYTH? Nearly 98% of patients with PBC suffer from the typical form of the disease, characterized by the slow, progressive decline of small bile ducts and increase in liver fibrosis.
While between 70%-‐85% of patients suffer from what is known as “typical PBC,” as many as 30% suffer from more rapid or severe forms of the disease.1
Space is limited. RSVP July 30th to: Email: email@example.comPhone: 844-‐350-‐1660
If you have any questions, please contact your Intercept representative, Stephanie Filoteo, at (215) 779-‐4011 or via e-‐mail at firstname.lastname@example.org.
Please be aware that if you are a licensed US physician, any meals provided are reportable under the Federal Open Payments/Sunshine Act. Attendance at this program is limited to healthcare professionals. Accordingly, attendance by guests or spouses cannot be accommodated.
- Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52(5):745-‐ 758.